dalteparin has been researched along with Paraplegia in 7 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Paraplegia: Severe or complete loss of motor function in the lower extremities and lower portions of the trunk. This condition is most often associated with SPINAL CORD DISEASES, although BRAIN DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; and MUSCULAR DISEASES may also cause bilateral leg weakness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Paraplegia (as opposed to tetraplegia) was the only risk factor identified for VTE." | 5.35 | Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort study. ( Anderson, D; Douglas, JA; Pike, J; Short, C; Thompson, K; Worley, S, 2008) |
| "Calcifying panniculitis is a rare form of calcinosis cutis belonging to the spectrum of calciphylaxis that has almost invariably been described in patients with severe renal disturbances." | 2.43 | Calcifying panniculitis following subcutaneous injections of nadroparin-calcium in a patient with osteomalacia. ( Borradori, L; Campanelli, A; Kaya, G; Masouyé, I, 2005) |
| "Paraplegia (as opposed to tetraplegia) was the only risk factor identified for VTE." | 1.35 | Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort study. ( Anderson, D; Douglas, JA; Pike, J; Short, C; Thompson, K; Worley, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campanelli, A | 1 |
| Kaya, G | 1 |
| Masouyé, I | 1 |
| Borradori, L | 1 |
| Heppner, PA | 1 |
| Monteith, SJ | 1 |
| Law, AJ | 1 |
| Sternlo, JE | 1 |
| Hybbinette, CH | 1 |
| Rachmani, R | 1 |
| Levi, Z | 1 |
| Zissin, R | 1 |
| Bernheim, J | 1 |
| Korzets, Z | 1 |
| Feltracco, P | 1 |
| Galligioni, H | 1 |
| Barbieri, S | 1 |
| Ori, C | 1 |
| Worley, S | 1 |
| Short, C | 1 |
| Pike, J | 1 |
| Anderson, D | 1 |
| Douglas, JA | 1 |
| Thompson, K | 1 |
2 reviews available for dalteparin and Paraplegia
| Article | Year |
|---|---|
Calcifying panniculitis following subcutaneous injections of nadroparin-calcium in a patient with osteomalacia.
Topics: Anticoagulants; Calciphylaxis; Depression; Female; Humans; Injections, Subcutaneous; Middle Aged; Na | 2005 |
Spontaneous spinal hematomas and low-molecular-weight heparin. Report of four cases and review of the literature.
Topics: Aged; Anticoagulants; Cervical Vertebrae; Enoxaparin; Follow-Up Studies; Hematoma; Humans; Male; Mid | 2004 |
5 other studies available for dalteparin and Paraplegia
| Article | Year |
|---|---|
[Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients].
Topics: Administration, Oral; Age Factors; Aged; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation | 2006 |
Spinal subdural bleeding after attempted epidural and subsequent spinal anaesthesia in a patient on thromboprophylaxis with low molecular weight heparin.
Topics: Aged; Anesthesia, Epidural; Anesthesia, Spinal; Enoxaparin; Female; Hematoma, Epidural, Cranial; Hem | 1995 |
Acute renal failure and paraplegia in a patient with a pelvic-ring fracture.
Topics: Acute Kidney Injury; Anticoagulants; Enoxaparin; Fractures, Bone; Hematoma; Humans; Hydronephrosis; | 2000 |
Transient paraplegia after epidural catheter removal during low molecular heparin prophylaxis.
Topics: Aged; Anesthesia, Epidural; Anticoagulants; Catheterization; Dalteparin; Device Removal; Female; Hum | 2014 |
Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort study.
Topics: Acute Disease; Adult; Aged; Anticoagulants; Cohort Studies; Dalteparin; Female; Heparin; Humans; Inc | 2008 |